GE HealthCare

GE HealthCare has agreed to acquire Sofie, a medical-imaging technology company, in a deal valued at close to $1 billion, according to a Wall Street Journal exclusive. The acquisition is aimed at expanding GE HealthCare's medical-imaging business, strengthening its position in diagnostics and imaging technology as demand for advanced healthcare imaging grows.

GE HealthCare is showcasing its photon-counting CT technology, a next-generation imaging approach that measures individual X-ray photons for sharper images at potentially lower radiation doses. The company's work in this area places it among the major imaging firms racing to bring the technology into routine clinical use, drawing attention from healthcare industry observers.

The Trump administration has finalized its Transparency in Coverage rules, requiring health insurers to disclose pricing information to consumers. The move is aimed at giving patients clearer insight into the real cost of medical care and coverage. The finalized rules have drawn attention as a significant step in healthcare pricing reform, with debate expected over their impact on insurers and patients.

GE HealthCare has agreed to acquire Sofie Biosciences for $945 million, a deal aimed at strengthening the company's radiopharmaceutical business. Radiopharmaceuticals, which combine radioactive compounds with targeted therapies for diagnostics and cancer treatment, are a fast-growing area of medical technology, and the acquisition signals GE HealthCare's push to expand beyond imaging equipment into this market.